Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Herzer

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Annals of the New York Academy of Sciences|January 1, 1988
Antibiotic therapy of early European Lyme borreliosis and acrodermatitis chronica atrophicansK Weber, V Preac-Mursic, U Neubert, et al.
Annals of the Rheumatic Diseases|July 14, 2016
Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDsA Strangfeld, A Richter, B Siegmund, et al.
Medical Microbiology and Immunology|November 1, 1993
Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzyme-linked immunosorbent assayB Wilske, V Fingerle, P Herzer, et al.
The Journal of Clinical Investigation|September 1, 1992
Cellular immune reactivity to recombinant OspA and flagellin from Borrelia burgdorferi in patients with Lyme borreliosis. Complexity of humoral and cellular immune responsesA Krause, G R Burmester, A Rensing, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1989
Prolyl 4-hydroxylase: molecular cloning and the primary structure of the alpha subunit from chicken embryoJ A Bassuk, W W Kao, P Herzer, et al.
Annals of the Rheumatic Diseases|February 15, 2005
Treatment continuation in patients receiving biological agents or conventional DMARD therapyA Zink, J Listing, S Kary, et al.
Zeitschrift Fur Rheumatologie|October 15, 2021
[Development of quality standards for patients with rheumatoid arthritis for use in Germany]U Kiltz, V Buschhorn-Milberger, K Albrecht, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Annals of the New York Academy of Sciences|January 1, 1988
Antibiotic therapy of early European Lyme borreliosis and acrodermatitis chronica atrophicansK Weber, V Preac-Mursic, U Neubert, et al.
Annals of the Rheumatic Diseases|July 14, 2016
Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDsA Strangfeld, A Richter, B Siegmund, et al.
Medical Microbiology and Immunology|November 1, 1993
Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzyme-linked immunosorbent assayB Wilske, V Fingerle, P Herzer, et al.
The Journal of Clinical Investigation|September 1, 1992
Cellular immune reactivity to recombinant OspA and flagellin from Borrelia burgdorferi in patients with Lyme borreliosis. Complexity of humoral and cellular immune responsesA Krause, G R Burmester, A Rensing, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1989
Prolyl 4-hydroxylase: molecular cloning and the primary structure of the alpha subunit from chicken embryoJ A Bassuk, W W Kao, P Herzer, et al.
Annals of the Rheumatic Diseases|February 15, 2005
Treatment continuation in patients receiving biological agents or conventional DMARD therapyA Zink, J Listing, S Kary, et al.
Zeitschrift Fur Rheumatologie|October 15, 2021
[Development of quality standards for patients with rheumatoid arthritis for use in Germany]U Kiltz, V Buschhorn-Milberger, K Albrecht, et al.
Pageof 5